Quantcast

Latest NewCardio Inc. Stories

2010-04-08 07:00:00

NEW YORK, April 8 /PRNewswire-FirstCall/ -- Clinilabs, a New York-based contract research organization that provides early phase and specialty clinical drug development services to the pharmaceutical industry, announced today that it has signed a Master Services Agreement (MSA) with NewCardio, Inc. (OTC Bulletin Board: NWCI), a cardiac diagnostic technology provider. Clinilabs has licensed NewCardio's QTinno(TM) software solution in order to perform fully-automated cardiac safety...

2010-03-18 07:00:00

SANTA CLARA, Calif., March 18 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today that a U.S.-based CRO that provides early phase and specialty clinical drug development services to the pharmaceutical industry, has signed an MSA, licensing NewCardio's QTinno(TM) software solution in order to deliver fully automated cardiac safety analysis in early phase QT studies. In addition, the CRO has signed a services work...

2010-02-25 07:00:00

SANTA CLARA, Calif., Feb. 25 /PRNewswire-FirstCall/ -- NewCardio, Inc. (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent covering technology relating to NewCardio's Cardio3KG solution (formerly VisualECG or Visual3Dx). This represents the core patent for NewCardio's anticipated emergency/urgent care solution, Cardio3KG. The Cardio3KG...

2010-02-22 07:00:00

SAN JOSE, Calif., Feb. 22 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today that the Heart Rhythm Society (HRS) has accepted an abstract detailing the superior performance of NewCardio's patented CardioBip(TM) technology for remote wireless monitoring and detection of atrial fibrillation (AF). The study results, which discuss the use of CardioBip for improved AF monitoring and detection, are scheduled for oral...

2010-02-04 07:00:00

SAN JOSE, Calif., Feb. 4 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today that its Chief Medical Officer, Ihor Gussak MD, PhD, FACC, world-recognized expert in electrocardiology and cardiac safety, will provide a special lecture at the prestigious Japanese Idiopathic Ventricular Fibrillation (J-IVFS) Annual Meeting at the Sankei Plaza convention center in Tokyo, Japan on February 8, 2010. Dr. Gussak's...

2010-01-14 08:00:00

SAN JOSE, Calif., Jan. 14 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today that on January 12, 2010, it received notice of allowance for U.S. patent 7,647,093, titled "Apparatus and method for cordless recording and telecommunication transmission of three special ECG leads and their processing," from the U.S. Patent and Trademark Office. This represents the core patent for CardioBip(TM) and, in conjunction with...

2010-01-06 07:00:00

SANTA CLARA, Calif., Jan. 6 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today that CEO, Dr. Branislav Vajdic, and CFO, Richard Brounstein, will present at the OneMedPlace Finance Forum 2010 at 2:45 p.m. (PT) on Tuesday, January 12, 2010 at The Sir Francis Drake Hotel in San Francisco, with a 40-minute breakout session to follow. Company management will be available for one-on-one meetings on January 12th, 13th...

2010-01-05 07:00:00

SANTA CLARA, Calif., Jan. 5 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today two encouraging validation studies related to CardioBip(TM), a hand-held patient-activated device for recording and wireless transmission of reconstructed 12-lead ECGs. The studies confirmed the product's ability to accurately provide wireless remote patient monitoring. As stated previously in regulatory filings, NewCardio, Inc....

2009-12-22 07:00:00

SANTA CLARA, Calif., Dec. 22 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that Dr. Ihor Gussak, Ph.D., F.A.C.C., NewCardio's Vice President and Chief Medical Officer, will join a distinguished roster of speakers, moderators and panelists at the Center for Business Intelligence (CBI) 4th Annual Cardiac Safety Assessment Summit. The Conference is scheduled for January 12 and 13, 2010, at the Madison A Loews...

2009-11-23 07:00:00

SANTA CLARA, Calif., Nov. 23 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today that CEO, Dr. Branislav Vajdic, and CFO, Richard Brounstein, will present at the 2nd Annual LD MICRO Conference on Thursday, December 3rd, at 4:30 PM PST at the Luxe Sunset Hotel in Los Angeles. Company management will be available for one-on-one meetings on Wednesday, December 2nd and Thursday, December 3rd. Please contact Brett...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related